BridgeMD
New treatment option for Low Back Pain
Official title Transcutaneous Electrical Nerve Stimulation (TENS) for the Treatment of Low Back Pain (LBP) in Adults
ClinicalTrials.gov ID: NCT07368920
What this study is testing
- What it's testing
- The goal of this clinical trial is to assess the effects and safety of transcutaneous electrical nerve stimulation (TENS) in adults with myofascial low back pain. Eligible participants will receive TENS treatment 5 times per week for 4 weeks.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Adults aged 18-65 years
- Diagnosis consistent with myofascial low back pain (localized low back pain with a palpable taut band; referred pain and/or sensory changes near a...
- Mild pain intensity at baseline (VAS \< 4 on a 0-10 scale)
- Symptom duration \> 1 month
- Able to understand the study procedures and demonstrate good compliance/cooperation
You likely can't join if
- Low back pain due to other causes, including but not limited to lumbar disc herniation, lumbar spinal stenosis, ankylosing spondylitis, spinal tumor...
- Received physical therapy, treatment procedures, or medication treatment within 4 weeks prior to enrollment that may affect pain or function...
- Systemic disease or organ dysfunction
- Skin/soft tissue breakdown or infection at/near the planned treatment area
- Use of sedative medications or opioid analgesics within 6 months prior to enrollment, or currently receiving other treatments that may affect study...
- Severe psychiatric disorder or inability to cooperate with study procedures
See the full eligibility criteria
- Adults aged 18-65 years
- Diagnosis consistent with myofascial low back pain (localized low back pain with a palpable taut band; referred pain and/or sensory changes near a specific trigger point; an identifiable tender spot within the taut...
- Mild pain intensity at baseline (VAS \< 4 on a 0-10 scale)
- Symptom duration \> 1 month
- Able to understand the study procedures and demonstrate good compliance/cooperation
- Written informed consent provided
- Low back pain due to other causes, including but not limited to lumbar disc herniation, lumbar spinal stenosis, ankylosing spondylitis, spinal tumor, spinal tuberculosis, or spinal infection
- Received physical therapy, treatment procedures, or medication treatment within 4 weeks prior to enrollment that may affect pain or function assessment
- Systemic disease or organ dysfunction
- Skin/soft tissue breakdown or infection at/near the planned treatment area
- Use of sedative medications or opioid analgesics within 6 months prior to enrollment, or currently receiving other treatments that may affect study outcomes
- Severe psychiatric disorder or inability to cooperate with study procedures
- Pregnant or breastfeeding women
The study team makes the final eligibility decision.
Where it's taking place
- Xi'an, Shaanxi, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Xi'an, Shaanxi, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.